electroCore, Inc. develops and commercializes non-invasive medical devices that utilize neuromodulation technology to treat pain and chronic conditions. Its primary product, gammaCore, is a non-invasive vagus nerve stimulator designed to improve patient outcomes. The company operates in various markets, including the United States, United Kingdom, European Union, Canada, Australia, New Zealand, and Saudi Arabia, and maintains an extensive intellectual property portfolio related to its technology.
